SS Innovations Reports Record Q2 Revenue, Up 39.4%
SS Innovations Q2 revenue hits record $13.9M, up 39.4%, driven by SSi Mantra surgical robot adoption. FDA clearance and CE marking on horizon.
The continued growth of SS Innovations and its SSi Mantra system signals a transformative shift in surgical robotics, making advanced minimally invasive surgery more accessible globally. As the company expands its installed base and works toward regulatory approvals in the U.S. and Europe, patients may benefit from improved outcomes and shorter recovery times. Investors should note the company's strong financial performance and potential catalysts ahead.